FTC v. Actavis, Inc. (In re Androgel Antitrust Litigation (II) (N.D. Ga.)

by Robins Kaplan LLP

Case Name: FTC v. Actavis, Inc. (In re: Androgel Antitrust Litigation (II), Case No. 1:09-CV-955-TWT, 2014 U.S. Dist. LEXIS 54808 (N.D. Ga. Apr. 18, 2014) (Thrash, J.)

Drug Product and Patent(s)-in-Suit: Androgel®; U.S. Pat. No. 6,503,894 (“the ’894 patent”) 

Nature of the Case and Issue(s) Presented:  In FTC v. Actavis, Inc., 133 S. Ct. 2223 (2013), the Supreme Court reversed and remanded to the district court to apply a rule of reason analysis to defendants’ reverse payment settlement.  On remand, defendants Solvay and Par/Paddock renewed their motion to dismiss arguing that the reverse payment settlement is protected by the Noerr-Pennington doctrine because the underlying litigation was terminated by a consent judgment. In the underlying litigation, while summary judgment motions were pending, the parties reached a settlement and licensing agreement. Solvay agreed to a consent judgment dismissing the infringement action. Par/Paddock agreed not to market generic AndroGel until the earlier of August 31, 2015 or the date another company launched a generic. Solvay also agreed to share profits with Par and Paddock. Par agreed to promote AndroGel to primary care physicians. Paddock agreed to serve as a backup supplier for AndroGel. The profit sharing and business promotion agreements were not disclosed to the court and not recited in the consent judgment. Despite the agreements not to disclose this information, defendants filed a motion to dismiss the complaint because the settlement agreement was a legitimate petitioning for government action and thus protected by the Noerr-Pennington doctrine. The court denied defendants’ motion to dismiss.

Why FTC Prevailed:  The court based its decision on the following: (i) the settlement agreement did not involve the court or disclose the full scope of the agreement; (ii) the Supreme Court’s Noerr-Pennington precedent read in light of its Actavis decision counsels against immunizing reverse payment agreements; and (iii) consent judgments of this nature should not generally be afforded Noerr-Pennington immunity. The court analogized the instant case to two reverse payment cases: In re Nexium (Esomeprazole) Antitrust Litigation, No. 12-md-02409-WGY, 2013 U.S. Dist. LEXIS 129696 (D. Mass. Sept. 11, 2013) (“Nexium”) and In re Ciprofloxacin Hydrochloride Antitrust Litigation, 261 F. Supp. 2d 188 (E.D.N.Y. 2003) (“Cipro”). In Cipro, Noerr-Pennington immunity did not apply because the consent judgment itself did not include all the terms of the agreement. Like in Cipro, immunity also did not apply in Nexium because the court did not play an independent role in drafting the terms of the consent judgment. The court entering the consent judgment does not mean that it substantively agreed to the terms.  Moreover, the court stated that “the holding in Actavis indicates that Noerr-Pennington should not protect the reverse payment settlement.” Since the anticompetitive nature of defendants’ settlement must be based on the payment size, its relation to anticipated litigation costs, independence from other services and lack of any other justification, defendants’ agreement is precisely the type of agreement that should have its validity determined by antitrust law. Finally, the court reasoned that the nature of a consent decree counsels against immunity. Consent decrees are voluntary between the parties and do not have preclusive effect against non-parties. Thus, the consent judgment is not the sort of government action that is typically due Noerr-Pennington immunity.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robins Kaplan LLP | Attorney Advertising

Written by:

Robins Kaplan LLP

Robins Kaplan LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.